Functional cortical effects of novel allelic variants of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) in humans

Pharmacopsychiatry

Volumn 40, Issue 5, 2007, Pages 191-195

  Gallinat, J ^a   Muller D J ^a   Bierbrauer, J ^a   Rommelspacher, H ^a   Juckel, G ^a,b   Wernicke, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; SEROTONIN TRANSPORTER;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; EVOKED AUDITORY RESPONSE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; ALLELES; CEREBRAL CORTEX; DNA; EVOKED POTENTIALS, AUDITORY; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; VARIATION (GENETICS);

EID: 35148867110     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-984464     Document Type: Article

References (55)

1. Brambilla P, Cipriani A, Hotopf M, Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 2005; 38: 69-77
2. Brocke B, Beauducel A, John R, Debener S, Heilemann H. Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 2000; 41: 24-30
3. Cavallini MC, Bella D Di, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 2002; 114: 347-353
4. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, Sham P, Vallada H et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 2005; 10: 771-781
5. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Am J Psychiatry 2001 ; 158: 1687-1692
6. DeLuca V, Tharmalingam S, King N, Strauss J, Bulgin N, Kennedy JL. Association study of a novel functional polymorphism of the serotonin transporter gene in bipolar disorder and suicidal behaviour. Psychopharmacology (Berl) 2005; 182: 128-131
7. Luca V De, Zai G, Tharmalingam S, Bartolomeis A de, Wong G, Kennedy JL. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia. Eur Neuropsychopharmacol 2006; 16: 268-271
8. Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J 2002; 2: 176-181
9. Dierks T, Barta S, Demisch L, Schmeck K, Englert E, Kewitz A et al. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology (Berl) 1999; 146: 101-107
10. Ferre S, Artigas F. Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 1993; 61: 772-775
11. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000; 148: 404-411
12. Gallinat J, Hellweg R, Lang UE. Indicators of central serotonergic activity: How "specific" is neurotransmission? Neuropsychopharmacology 2005; 30: 1586-1587
13. Gallinat J, Kunz D, Lang UE, Kalus P, Juckel G, Eggers J et al. Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing. Pharmacopsychiatry 2005; 38: 158-160
14. Gallinat J, Mulert C, Bajbouj M, Herrmann WM, Schunter J, Senkowski D et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002; 17: 110-127
15. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T et al. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 2003; 28: 530-532
16. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248: 96-103
17. Hegerl U, Juckel G, Schmidt LG, Rommelspacher H. Serotonergic ethanol effects and auditory evoked dipole activity in alcoholic and healthy subjects. Psychiatry Res 1996; 63: 47-55
18. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-649
19. Hensch T, Wargelius HL, Herold U, Lesch KP, Oreland L, Brocke B. Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials. Neuropsychopharmacology 2006; 31: 2047-2054
20. Hoefgen B, Schulze TG, Ohlraun S, Widdern O von, Hofels S, Gross M et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005; 57: 247-251
21. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006; 78: 815-826
22. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8-16
23. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000; 157: 1700-1703
24. Jucket G, Hegerl U. Evoked potentials, serotonin, and suicidality. Pharmacopsychiatry 1994; 27 (Suppl 1): 27-29
25. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999; 21: 710-716
26. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 1997; 41: 1181-1195
27. Kahkonen S, Jaaskelainen IP, Pennanen S, Liesivuori J, Ahveninen J. Acute tryptophan depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology (Berl) 2002; 164: 221-227
28. Lang UE, Bajbouj M, Wernicke C, Rommelspacher H, Danker-Hopfe H, Gallinat J. No association of a functional polymorphism in the serotonin transporter gene promoter and anxiety-related personality traits. Neuropsychobiology 2004; 49: 182-184
29. Lang UE, Hellweg R, Gallinat J. Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 2005; 30: 1148-1153
30. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 2005; 133: 110-115
31. Lee TW, Yu YW, Chen TJ, Tsai SJ. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 2005; 30: 202-205
32. Lesch KP, Bengel D, Heils A, Sabot SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531
33. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998; 44: 179-192
34. Lewis DA, Campbell MJ, Foote SL, Morrison JH. The monoaminergic innervation of primate neocortex. Hum Neurobiol 1986; 5: 181-188
35. Linka T, Muller BW, Bender S, Sartory G, Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 2005; 38: 139-143
36. Marazziti D, Dell'Osso B, Baroni S, Betti L, Catena M, Giannaccini G et al. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients. Pharmacopsychiatry 2006; 39: 35-38
37. Martin-Ruiz R, Ugedo L, Honrubia MA, Mengod G, Artigas F. Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. J Neurochem 2001; 77: 762-775
38. Morrison JH, Foote SL, Molliver ME, Bloom FE, Lidov HG. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. Proc Natl Acad Sci USA 1982; 79: 2401-2405
39. Mulert C, Juckel G, Augustin H, Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002; 113: 1566-1572
40. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5: 32-38
41. Nathan PJ, O'Neill B, Croft RJ. Is the loudness dependence of the auditory evoked potential a sensitive and selective in vivo marker of central serotonergic function? Neuropsychopharmacology 2005; 30: 1584-1585 ; author reply: 1586-1587
42. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 2006; 21: 47-52
43. Neuhaus A, Bajbouj M, Kienast T, Kalus P, Haebler D von, Winterer G et al. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology (Berl) 2006; 186: 191-200
44. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G et al. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 2004; 29: 1910-1917
45. Rupp D, Juckel G, Mavrogiorgou P, Goebel C, Zaudig M, Hegerl U. Serotonergic dysfunction in OCD assessed by auditory evoked potentials. World Congress of Biological Psychiatry (Abstract book) 2001
46. Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry 1998; 43: 908-912
47. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M et al. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 1997; 21: 1356-1359
48. Scherg M, Berg P. Use of prior knowledge in brain electromagnetic source analysis. Brain Topogr 1991; 4: 143-150
49. Schuckit MA, Mazzanti C, Smith TL, Ahmed U, Radel M, Iwata N et al. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry 1999; 45: 647-651
50. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004; 127: 85-89
51. Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 2003; 53: 304-314
52. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20): 22-33 ; quiz: 34-57
53. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 2003; 118: 41-47
54. Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz S et al. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 2000; 22: 608-617
55. 123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 2004; 161: 525-531